These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 33361693)

  • 21. Metabolic effects of biosynthetic growth hormone treatment in severely energy-restricted obese women.
    Tagliaferri M; Scacchi M; Pincelli AI; Berselli ME; Silvestri P; Montesano A; Ortolani S; Dubini A; Cavagnini F
    Int J Obes Relat Metab Disord; 1998 Sep; 22(9):836-41. PubMed ID: 9756240
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Body composition during GH replacement in adults - methodological variations with respect to gender.
    Koranyi J; Bosaeus I; Alpsten M; Bengtsson BA; Johannsson G
    Eur J Endocrinol; 2006 Apr; 154(4):545-53. PubMed ID: 16556717
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long-term effects of growth hormone replacement therapy on liver function in adult patients with growth hormone deficiency.
    Matsumoto R; Fukuoka H; Iguchi G; Nishizawa H; Bando H; Suda K; Takahashi M; Takahashi Y
    Growth Horm IGF Res; 2014 Oct; 24(5):174-9. PubMed ID: 25116471
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Relationship between GH-induced metabolic changes and changes in body composition: a dose and time course study in GH-deficient adults.
    Burt MG; Gibney J; Hoffman DM; Umpleby AM; Ho KK
    Growth Horm IGF Res; 2008 Feb; 18(1):55-64. PubMed ID: 17714967
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Gender variation in leptin circadian rhythm and pulsatility in adult growth hormone deficiency: effects of growth hormone replacement.
    White HD; Ahmad AM; Guzder R; Wallace AM; Fraser WD; Vora JP
    Clin Endocrinol (Oxf); 2003 Apr; 58(4):482-8. PubMed ID: 12641632
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Differential effects of raloxifene and estrogen on body composition in growth hormone-replaced hypopituitary women.
    Birzniece V; Meinhardt UJ; Gibney J; Johannsson G; Armstrong N; Baxter RC; Ho KK
    J Clin Endocrinol Metab; 2012 Mar; 97(3):1005-12. PubMed ID: 22170716
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Modulation of cortisol metabolism by low-dose growth hormone replacement in elderly hypopituitary patients.
    Toogood AA; Taylor NF; Shalet SM; Monson JP
    J Clin Endocrinol Metab; 2000 Apr; 85(4):1727-30. PubMed ID: 10770221
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Efficacy, safety and compliance of long-term growth hormone (GH) replacement therapy in adults with GH deficiency].
    Zaninelli DC; Meister LH; Radominski RB; Borba VZ; Souza AM; Boguszewski CL
    Arq Bras Endocrinol Metabol; 2008 Jul; 52(5):879-88. PubMed ID: 18797596
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Circadian and ultradian rhythm and leptin pulsatility in adult GH deficiency: effects of GH replacement.
    Ahmad AM; Guzder R; Wallace AM; Thomas J; Fraser WD; Vora JP
    J Clin Endocrinol Metab; 2001 Aug; 86(8):3499-506. PubMed ID: 11502770
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Growth hormone improves body composition, fat utilization, physical strength and agility, and growth in Prader-Willi syndrome: A controlled study.
    Carrel AL; Myers SE; Whitman BY; Allen DB
    J Pediatr; 1999 Feb; 134(2):215-21. PubMed ID: 9931532
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Growth hormone (GH) replacement therapy in adult-onset gh deficiency: effects on body composition in men and women in a double-blind, randomized, placebo-controlled trial.
    Hoffman AR; Kuntze JE; Baptista J; Baum HB; Baumann GP; Biller BM; Clark RV; Cook D; Inzucchi SE; Kleinberg D; Klibanski A; Phillips LS; Ridgway EC; Robbins RJ; Schlechte J; Sharma M; Thorner MO; Vance ML
    J Clin Endocrinol Metab; 2004 May; 89(5):2048-56. PubMed ID: 15126520
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prevalence of low lean mass in patients with adult growth hormone deficiency with or without low-dose growth hormone therapy.
    Zheng X; Cheng Q; Long J; Wang Y; Gong L; Wei Q; Luo R; Liao K; Ren W
    Clin Endocrinol (Oxf); 2019 Jun; 90(6):834-841. PubMed ID: 30817014
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Serum afamin and its implications in adult growth hormone deficiency: a prospective GH-withdrawal study.
    Ratku B; Lőrincz H; Csiha S; Sebestyén V; Berta E; Bodor M; Nagy EV; Szabó Z; Harangi M; Somodi S
    Front Endocrinol (Lausanne); 2024; 15():1348046. PubMed ID: 38379862
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Low-dose GH replacement improves the adverse lipid profile associated with the adult GH deficiency syndrome.
    Murray RD; Wieringa GE; Lissett CA; Darzy KH; Smethurst LE; Shalet SM
    Clin Endocrinol (Oxf); 2002 Apr; 56(4):525-32. PubMed ID: 11966746
    [TBL] [Abstract][Full Text] [Related]  

  • 35. GH administration and discontinuation in healthy elderly men: effects on body composition, GH-related serum markers, resting heart rate and resting oxygen uptake.
    Lange KH; Isaksson F; Rasmussen MH; Juul A; Bülow J; Kjaer M
    Clin Endocrinol (Oxf); 2001 Jul; 55(1):77-86. PubMed ID: 11453955
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Limited effects of growth hormone replacement in patients with GH deficiency during long-term cure of acromegaly.
    van der Klaauw AA; Bax JJ; Roelfsema F; Stokkel MP; Bleeker GB; Biermasz NR; Smit JW; Romijn JA; Pereira AM
    Pituitary; 2009; 12(4):339-46. PubMed ID: 19521779
    [TBL] [Abstract][Full Text] [Related]  

  • 37. One year of GH replacement therapy with a fixed low-dose regimen improves body composition, bone mineral density and lipid profile of GH-deficient adults.
    Boguszewski CL; Meister LH; Zaninelli DC; Radominski RB
    Eur J Endocrinol; 2005 Jan; 152(1):67-75. PubMed ID: 15762189
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sheehan's syndrome: baseline characteristics and effect of 2 years of growth hormone replacement therapy in 91 patients in KIMS - Pfizer International Metabolic Database.
    Kelestimur F; Jonsson P; Molvalilar S; Gomez JM; Auernhammer CJ; Colak R; Koltowska-Häggström M; Goth MI
    Eur J Endocrinol; 2005 Apr; 152(4):581-7. PubMed ID: 15817914
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Human growth hormone replacement in adult hypopituitary patients: long-term effects on body composition and lipid status--3-year results from the HypoCCS Database.
    Attanasio AF; Bates PC; Ho KK; Webb SM; Ross RJ; Strasburger CJ; Bouillon R; Crowe B; Selander K; Valle D; Lamberts SW;
    J Clin Endocrinol Metab; 2002 Apr; 87(4):1600-6. PubMed ID: 11932289
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Medium and long-term outcome of growth hormone therapy in growth hormone deficient adults.
    Fideleff HL; Boquete H; Giaccio A; Sobrado P;
    Medicina (B Aires); 2006; 66(4):296-302. PubMed ID: 16977963
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.